CircCDK1 knockdown reduces CDK1 expression by targeting miR-489-3p to suppress the development of breast cancer and strengthen the sensitivity of Tamoxifen.

Liu, Di; Zhou, Zhangjian; Guo, Yize; Du, Qin; Li, Liang

Liu, Di; Zhou, Zhangjian; Guo, Yize; Du, Qin; Li, Liang.

Afiliação

Liu D; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi.
Zhou Z; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi.
Guo Y; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi.
Du Q; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi.
Li L; Department of Radiotherapy, Shaanxi Provincial Tumor Hospital, Xi'an, People's Republic of China.

Anticancer Drugs ; 33(3): 286-299, 2022 03 01.

Article em En | MEDLINE | ID: mdl-34924499

Assuntos

Neoplasias da Mama; MicroRNAs; Animais; Neoplasias da Mama/tratamento farmacológico; Neoplasias da Mama/genética; Proteína Quinase CDC2/genética; Feminino; Humanos; MicroRNAs/genética; MicroRNAs/metabolismo; RNA Circular; Tamoxifeno/farmacologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / MicroRNAs Tipo de estudo: Diagnostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Anticancer Drugs Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google